Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 2, 2005, Pages 420-425

  Sangar, Vijay K ^a   McBain, Catherine A ^b   Lyons, Jeanette ^b   Ramani, Vijay A C ^a   Logue, John P ^b   Wylie, James P ^b   Clarke, Noel W ^b   Cowan, Richard A ^b  

^a Department of Urology ^*

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bladder; Cancer; Gemcitabine; Radiotherapy

Indexed keywords

CELLS; CHEMOTHERAPY; DOSIMETRY; ONCOLOGY; TOXICITY; TUMORS;

BLADDER CANCER; CHEMORADIOTHERAPY; CONFORMAL RADIOTHERAPY; GEMCITABINE;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; GEMCITABINE;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BLADDER CARCINOMA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CHRONIC TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIARRHEA; DISEASE SEVERITY; DOSE CALCULATION; DOSIMETRY; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; HUMAN; LETHARGY; MALE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION SICKNESS; RADIODIAGNOSIS; STOMATITIS; TRANSITIONAL CELL CARCINOMA; URINARY TRACT DISEASE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, CONFORMAL; URINARY BLADDER NEOPLASMS;

EID: 12844285162     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.05.074     Document Type: Article

References (27)

1. B.J. Jenkins, M.J. Caulfield, C.G. Fowler Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/3) bladder cancer Br J Urol 62 1988 343 346
2. D.G. Skinner, J.R. Daniels, C.A. Russel The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial J Urol 145 1991 459 467
3. Shipley WU, Prout GR, Einstein AB, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery JAMA 1987;258:931-935.
4. J. Dunst, R. Sauer, K.M. Schrott Organ sparing treatment of advanced bladder cancer: A 10 year experience Int J Radiat Oncol Biol Phys 30 1994 261 266
5. M. Rotman, H. Aziz, M. Porrazzo Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion Int J Radiat Oncol Biol Phys 18 1990 1131 1137
6. C.M.L. Coppin, M.K. Gospodarowicz, K. James Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation J Clin Oncol 14 1996 2901 2907
7. W.U. Shipley, K.A. Winter, D.S. Kaufman Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Intial results of Radiation Therapy Oncology Group 89-03 J Clin Oncol 16 1999 3576 3583
8. D.S. Kaufman, K.A. Winter, W.U. Shipley The initial results in muscle invading bladder cancer of RTOG 95-06: Phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective preservation or cystectomy depending on the initial response Oncologist 5 2000 471 476
9. H. van der Maase, S.W. Hansen, J.T. Roberts Gemcitabine and cisplatin versus methotexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: Results of a large randomised, multinational, multicentre Phase III study J Clin Oncol 17 2000 3068 3077
10. W.M. Stadler, T. Kuzel, B. Roth Phase II study of single agent gemcitabine in previously untreated patients with metastatic urothelial cancer J Clin Oncol 15 1997 3394 3398
11. D.S. Shewach, T.M. Hahn, E. Hang Metabolism of 2,2-difluoro-2- deoxycytidine and radiation sensitisation of human colon carcinoma cells Cancer Res 54 1994 3218 3223
12. T.S. Lawrence, E. Chang, T.M. Hahn Radiosensitization of pancreatic cancer cells by 2,2-difluoro-2-deoxycytidine Int J Radiat Oncol Biol Phys 34 1996 867 872
13. K.A. Mason, L. Milas, N.R. Hunter Maximizing therapeutic gain with gemcitabine and fractionated radiation Int J Radiat Oncol Biol Phys 44 1999 1125 1135
14. S. Pacini, F. Milano, P. Pinzani Effects of gemcitabine in normal and transformed human lung cultures: Cytotoxicity and increase in radiation sensitivity Tumori 85 1999 503 507
15. M.T. Fields, A. Eisbruch, D. Normolle Radiosensitization produced in vivo by once vs twice weekly 2,2-difluoro-2-deoxycytidine (gemcitabine) Int J Radiat Oncol Biol Phys 47 2000 785 791
16. B.W. Robinson, D.S. Shewach Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines Clin Cancer Res 7 2001 2581 2589
17. A.W. Blackstock, S.A. Bernard, F. Richards Phase I trial of twice weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer J Clin Oncol 17 1999 2208 2212
18. J.W.G. van Putten, A. Price, A.H.D. van-der-Leest, A. Gregor, F.A. Little, H.J.M. Groen A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer Clin Cancer Res 9 2003 2472 2477
19. P. Pattaranutaporn, C. Thirapakawong, Y. Chansilpa Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma Gynecol Oncol 81 2001 404 407
20. M.A. Joschko, L.K. Webster, J. Groves Enhancement of radiation induced regrowth delay by gemcitabine in a human tumour xenograft model Radiat Oncol Invest 5 1997 62 71
21. J.M. Pipas, S.E. Mitchell, R.J. Barth Phase I study of twice weekly gemcitabine and concomitant external beam radiotherapy in patients with adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 50 2001 1317 1322
22. R.A. Wolf, D.B. Evans, D.M. Gravel Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Canc Res 7 2001 2246 2253
23. A. Eisbruch, D.S. Shewach, C.R. Bradford Radiation concurrent with gemcitabine for locally advanced head and neck cancer A phase I trial and intracellular drug incorporation study J Clin Oncol 19 2001 792 799
24. M. Tkeda, S. Okada, K. Tokuuye A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer Br J Cancer 86 2002 1551 1554
25. M. Mohiuddin, M. Kudrimoti, W.F. Regine Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: A phase I study J Cancer 8 2002 255 262
26. Smith D, Montie J, Sandler H, et al. Pilot trial of concurrent gemcitabine and radiotherapy as a bladder preservation strategy [Abstract]. Proc ASCO 2000;19:abstract #1419.
27. O. Caffo, G. Fellin, U. Graffer Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrative bladder cancer Int J Radiat Oncol Biol Phys 57 2003 1310 1316